当前位置: 首页? 政策法规? 国外法规? 欧盟拒绝某些食品的健康声?/a>

欧盟拒绝某些食品的健康声?/h1>
扫描二维 分享好友和朋友圈
放大字体缩小字体2017-07-07 08:39:38 来源9a href="http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2017.173.01.0006.01.ENG&toc=OJ:L:2017:173:TOC" target="_blank" rel="nofollow">欧盟委员伙/a> 浏览次数9span id="hits">4369
核心提示?017??日,欧盟发布(EU) 2017/1202法规,拒绝FHI LFC24,V0137等在食品的特定声称。欧盟拒绝授权低脂发酵牛奶和低聚果糖、益生菌的联合使用可以降低唇疱疹复发,FHI LFC24(自牛奶提前的酪蛋白水解物)可以调节食物消耗后的血糖水平,V0137(一种含鱼油的DHA)可以延缓记忆衰退功能的健康声称、/div>
发布单位
欧盟委员
欧盟委员伙/div>
发布文号 (EU) 2017/1202
发布日期 2017-07-05 生效日期 2017-07-26
有效性状?/th> 废止日期 暂无
备注 2017??日,欧盟发布(EU) 2017/1202法规,拒绝FHI LFC24,V0137等在食品的特定声称。欧盟拒绝授权低脂发酵牛奶和低聚果糖、益生菌的联合使用可以降低唇疱疹复发,FHI LFC24(自牛奶提前的酪蛋白水解物)可以调节食物消耗后的血糖水平,V0137(一种含鱼油的DHA)可以延缓记忆衰退功能的健康声称、/td>

COMMISSION REGULATION (EU) 2017/1202 of 5 July 2017

refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods (1), and in particular Article 18(5) thereof,

Whereas:

(1)

Pursuant to Regulation (EC) No 1924/2006 health claims made on foods are prohibited unless they are authorised by the Commission in accordance with that Regulation and included in a list of permitted claims.

(2)

Regulation (EC) No 1924/2006 also provides that applications for authorisations of health claims may be submitted by food business operators to the national competent authority of a Member State. The national competent authority is to forward valid applications to the European Food Safety Authority (EFSA), hereinafter referred to as the Authority, for a scientific assessment, as well as to the Commission and the Member States for information.

(3)

The Authority is to deliver an opinion on the health claim concerned.

(4)

The Commission is to decide on the authorisation of health claims taking into account the opinion delivered by the Authority.

(5)

Following an application from Granarolo S.p.A., submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to a low-fat fermented milk with a combination of fructooligosaccharides and live Lactobacillus rhamnosus GG (ATCC 53103), Streptococcus thermophilus (Z57) and Lactobacillus delbrueckii subsp. bulgaricus (LB2), and defence against reactivation of Herpes simplex virus in the orolabial epithelia (Question No EFSA-Q-2015-00488 (2)). The claim proposed by the applicant was worded as follows: Consumption of low-fat fermented milk with a combination of fructo-oligosaccharides (FOS) and live Lactobacillus rhamnosusGG (ATCC 53103), Streptococcus thermophilus (Z57) and Lactobacillus delbrueckii subsp. bulgaricus (LB2) helps to reduce recurrence of lip cold sores caused by Herpes simplex virus infection in healthy susceptible individuals.

(6)

On 19 July 2016, the Commission and the Member States received the scientific opinion from the Authority, which concluded that, on the basis of the data presented, a cause and effect relationship had not been established between the consumption of the low-fat fermented milk, which was the subject of the health claim, and defence against reactivation of Herpes simplex virus in the orolabial epithelia. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.

(7)

Following an application from Food for Health Ireland, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to FHI LFC24, a bovine milk-derived casein hydrolysate, and a reduction of post-prandial blood glucose responses (Question No EFSA- Q-2015-00755 (3)). The claim proposed by the applicant was worded as follows: FHI LFC24 helps to regulate blood glucose levels following food consumption.

(8)

On 22 July 2016, the Commission and the Member States received the scientific opinion from the Authority, which noted that the evidence provided by the applicant does not establish that a reduction in post-prandial glycaemic responses achieved by an increase in insulin secretion is a beneficial physiological effect for the target population of the claim. Therefore, on the basis of the data presented, the Authority concluded that a cause and effect relationship had not been established between the consumption of the food subject to the claim and a beneficial physiological effect for the target population. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.

(9)

Following an application from Pierre Fabre Medicament, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to V0137, a DHA-enriched fish oil, and helps to slow the age-related cognitive decline in domains such as memory and executive function (Question No EFSA- Q- 2016-00071 (4)). The claim proposed by the applicant was worded as follows: V0137, in association with physical and intellectual training, helps to slow the age-related cognitive decline in domains such as memory and executive function.

(10)

On 5 August 2016, the Commission and the Member States received the scientific opinion from the Authority, which concluded that, on the basis of the data presented, a cause and effect relationship had not been established between the consumption of V0137, which was the subject of the health claim, and a reduced loss of cognitive function. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.

(11)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 5 July 2017.

For the Commission

The President

Jean-Claude JUNCKER


(1) OJ L 404, 30.12.2006, p. 9.

(2) EFSA Journal 2016;14(7):4538

(3) EFSA Journal 2016;14(7):4540

(4) EFSA Journal 2016;14(8):4539


ANNEX

Rejected health claims

Application Relevant provisions of Regulation (EC) No 1924/2006

Nutrient, substance, food or food category

Claim

EFSA opinion reference

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Low-fat fermented milk with a combination of fructo-oligosaccharides (FOS) and live Lactobacillus rhamnosus GG (ATCC 53103), Streptococcus thermophilus (Z57) and Lactobacillus delbrueckii subsp. bulgaricus (LB2).

Consumption of low-fat fermented milk with a combination of fructo-oligosaccharides (FOS) and live Lactobacillus rhamnosus GG (ATCC 53103), Streptococcus thermophilus (Z57) and Lactobacillus delbrueckii subsp. bulgaricus (LB2) helps to reduce recurrence of lip cold sores caused by Herpes simplex virus infection in healthy susceptible individuals.

Q-2015-00488

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

FHI LFC24, a bovine milk-derived casein hydrolysate.

FHI LFC24 helps to regulate blood glucose levels following food consumption.

Q-2015-00755

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

V0137, a DHA enriched fish oil.

V0137, in association with physical and intellectual training, helps to slow the age-related cognitive decline in domains such as memory and executive function.

Q-2016-00071

食品伙伴网提供标准法规解读、舆情监控、合规咨询、申报注册等服务、br/>电询?535-2129301
QQ?891238009
食品标法? border=
实时把握 食品标法动?/span>
请扫码关?span class="color2">食品标法圇/span>

声明9/p>

凡本网所有原?编译文章及图片、图表的版权均属食品伙伴网所有,如要转载,需注明“信息来源:食品伙伴网”、br> 凡本网注明“信息来源:XXX(非食品伙伴网)”的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责、br> 邮箱:law#www.sqrdapp.com(发邮件时请?换成@ QQ?39307733

[ 政策法规搜索] [ 加入收藏] [ 告诉好友] [ 打印本文] [ 关闭窗口]

Baidu
map